GB201907016D0 - Screening method to determine suitability for participation in a clinical trial - Google Patents

Screening method to determine suitability for participation in a clinical trial

Info

Publication number
GB201907016D0
GB201907016D0 GBGB1907016.8A GB201907016A GB201907016D0 GB 201907016 D0 GB201907016 D0 GB 201907016D0 GB 201907016 A GB201907016 A GB 201907016A GB 201907016 D0 GB201907016 D0 GB 201907016D0
Authority
GB
United Kingdom
Prior art keywords
participation
clinical trial
screening method
determine suitability
suitability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1907016.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Biopharm Ltd
Original Assignee
Ipsen Biopharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsen Biopharm Ltd filed Critical Ipsen Biopharm Ltd
Priority to GBGB1907016.8A priority Critical patent/GB201907016D0/en
Publication of GB201907016D0 publication Critical patent/GB201907016D0/en
Priority to PCT/GB2020/051202 priority patent/WO2020234573A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M19/00—Local anaesthesia; Hypothermia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
GBGB1907016.8A 2019-05-17 2019-05-17 Screening method to determine suitability for participation in a clinical trial Ceased GB201907016D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1907016.8A GB201907016D0 (en) 2019-05-17 2019-05-17 Screening method to determine suitability for participation in a clinical trial
PCT/GB2020/051202 WO2020234573A1 (en) 2019-05-17 2020-05-15 Screening method to determine suitability for participation in a clinical trial

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1907016.8A GB201907016D0 (en) 2019-05-17 2019-05-17 Screening method to determine suitability for participation in a clinical trial

Publications (1)

Publication Number Publication Date
GB201907016D0 true GB201907016D0 (en) 2019-07-03

Family

ID=67385121

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1907016.8A Ceased GB201907016D0 (en) 2019-05-17 2019-05-17 Screening method to determine suitability for participation in a clinical trial

Country Status (2)

Country Link
GB (1) GB201907016D0 (en)
WO (1) WO2020234573A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202011055D0 (en) * 2020-07-17 2020-09-02 Ipsen Bioinnovation Ltd Treatment of post-operative pain
CN112967809B (en) * 2021-04-06 2024-01-23 联仁健康医疗大数据科技股份有限公司 Method, device, equipment and storage medium for determining follow-up user

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
AU777556B2 (en) 1999-08-25 2004-10-21 Allergan, Inc. Activatable recombinant neurotoxins
US6903187B1 (en) 2000-07-21 2005-06-07 Allergan, Inc. Leucine-based motif and clostridial neurotoxins
DE102004043009A1 (en) 2004-09-06 2006-03-23 Toxogen Gmbh Transport protein for introducing chemical compounds into nerve cells
DE102005019302A1 (en) 2005-04-26 2006-11-16 Toxogen Gmbh Carrier for targeting nerve cells
FR2930447B1 (en) * 2008-04-25 2010-07-30 Sod Conseils Rech Applic THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR THE TREATMENT OF PAIN IN THE CASE OF DIABETIC NEUROPATHY
EP2419128B1 (en) 2009-04-14 2018-06-06 Medical College of Wisconsin, Inc. Engineered botulinum neurotoxin
US8853360B2 (en) 2010-06-23 2014-10-07 Wisconsin Alumni Research Foundation Engineered botulinum neurotoxin C1 with selective substrate specificity
BR112019000278A2 (en) 2016-07-08 2019-04-24 Children's Medical Center Corporation botulinum neurotoxin and its derivatives

Also Published As

Publication number Publication date
WO2020234573A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
EP2693904A4 (en) Seamless upper for footwear and method for making the same
EP2209414A4 (en) A method for performing visual acuity testing
EP2780458A4 (en) Plants having enhanced yield-related traits and a method for making the same
EP2744744A4 (en) Ultra-light micro-lattices and a method for forming the same
ZA202204640B (en) Method for extracting kelp polyphenols
GB201907016D0 (en) Screening method to determine suitability for participation in a clinical trial
IL277852A (en) Method for carrying out a measurement process
IL260351B1 (en) Method for measuring tear constituents in a tear sample
PL398407A1 (en) Machine for cigarette making and method for cigarette making using the cigarette making machine
HK1245848A1 (en) Method for measuring a change in an individual's immunorepertoire
EP3995575A4 (en) Aptamer selection method and immunity analysis method using aptamer
EP2692454A4 (en) Press forming analysis method
IL291531A (en) A method for development ally- activating a cell
EP2442105A4 (en) Test method on renal diseases
TWI365504B (en) Die defect inspecting system for inspecting the defect of a back surface of a die and method for using the same
GB2491885B (en) A method and system for improving gear change quality
IL192650A0 (en) A method for defects enhancement
GB201917101D0 (en) Method for digesting nucleic acid in a sample
EP2734625A4 (en) Plants having enhanced yield-related traits and a method for making the same
HK1255013A1 (en) Method for drug binding analysis in a tissue sample
ZA200905849B (en) A method for evaluation of a gemstone
IL255311B (en) Method for measuring tear constituents in a tear sample
EP4022080A4 (en) Method for detecting american foulbrood in a beehive
ZA201308119B (en) Method for determining clinically relevant hypoxia in cancer
IL290657A (en) Method for enriching cardiac myocytes

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)